<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <title>Biobank | LiquidMammo™</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />

  <meta name="description"
        content="The MultiOmics Biobank supports LiquidMammo™ discovery and validation with longitudinal breast‑cancer samples, enabling retrospective microRNA panel testing." />

  <!-- Stylesheet -->
  assets/css/styles.css
  favicon.png
</head>

<body>

<!-- ======================================
     MINIMAL HEADER (← Home)
======================================= -->
<header class="container">
  <nav>
    index.html← Home</a>
  </nav>
</header>


<!-- ======================================
     MAIN CONTENT
======================================= -->
<main class="container">

  <h1>MultiOmics Biobank</h1>

  <!-- Overview -->
  <section class="section-tight">
    <p>
      The MultiOmics Biobank is a longitudinal breast‑cancer resource enabling rapid, retrospective
      discovery and validation of <span class="scientific-term">microRNA</span>‑based diagnostic panels.
      With samples reaching back to <strong>2008</strong>, researchers can test candidate molecular
      signatures against known outcomes before prospective studies.
    </p>
  </section>


  <!-- Proof points -->
  <section class="panel-light section-tight">
    <div class="grid" style="grid-template-columns:repeat(auto-fit,minmax(260px,1fr));">
      <div class="card">
        <h3>Scale & history</h3>
        <p>
          ~20,000 breast‑cancer samples with longitudinal clinical context, including cohorts back to
          <strong>2008</strong> — enabling retrospective performance assessment of candidate panels.
        </p>
      </div>

      <div class="card">
        <h3>Consent & provenance</h3>
        <p>
          The DNA consent pathway was originally developed at <strong>Baylor</strong>. Samples and data are
          maintained by <strong>MultiOmics</strong> with consent‑based access controls and participant protection.
        </p>
      </div>
    </div>
  </section>


  <!-- What we bank -->
  <section class="section-tight">
    <h2>What we bank</h2>

    <div class="grid" style="grid-template-columns:repeat(auto-fit,minmax(260px,1fr));">

      <div class="card-mini">
        <h4>Specimens</h4>
        <p class="small">
          Blood‑based materials suitable for <span class="scientific-term">microRNA</span> profiling.
          Where available, paired tissue or additional biospecimens support biology‑aware modeling.
        </p>
      </div>

      <div class="card-mini">
        <h4>Linked clinical data</h4>
        <p class="small">
          Longitudinal context (diagnosis, subtype, imaging confirmation, and time‑to‑event where
          available) supports rigorous label definition. Datasets are de‑identified prior to release.
        </p>
      </div>

    </div>
  </section>


  <!-- Use cases -->
  <section class="section-tight">
    <h2>How investigators use the biobank</h2>

    <div class="grid" style="grid-template-columns:repeat(auto-fit,minmax(260px,1fr));">

      <div class="card-mini">
        <h4>Discovery</h4>
        <p class="small">
          Identify and refine candidate <span class="scientific-term">microRNA</span> signatures, optimize
          normalization, feature selection, and modeling approaches.
        </p>
      </div>

      <div class="card-mini">
        <h4>Retrospective validation</h4>
        <p class="small">
          Evaluate sensitivity, specificity, AUC, and subgroup performance using historical samples
          with known outcomes — reducing risk ahead of prospective studies.
        </p>
      </div>

    </div>
  </section>


  <!-- Governance -->
  <section id="governance" class="panel-light section-tight">
    <h2>Governance & participant protections</h2>

    <div class="grid" style="grid-template-columns:repeat(auto-fit,minmax(260px,1fr));">

      <div class="card-mini">
        <h4>Consent & privacy</h4>
        <p class="small">
          All access follows informed‑consent pathways with strict data‑minimization and privacy
          safeguards. Only de‑identified outputs leave MultiOmics environments.
        </p>
      </div>

      <div class="card-mini">
        <h4>Scientific & ethics review</h4>
        <p class="small">
          Requests undergo documented review for scientific merit, feasibility, and ethical
          compliance. IRB documentation required when applicable.
        </p>
      </div>

    </div>
  </section>


  <!-- Access process -->
  <section id="access" class="section">
    <h2>Accessing the biobank</h2>

    <div class="grid" style="grid-template-columns:repeat(auto-fit,minmax(260px,1fr));">

      <div class="card">
        <h3>Who can apply</h3>
        <p>
          Academic, clinical, or industry researchers working on diagnostic discovery, validation, or
          clinical‑utility studies — especially early detection and dense‑breast challenges.
        </p>
      </div>

      <div class="card">
        <h3>How to request</h3>

        <ol class="list-tight">
          <li>Submit a 2–3 page concept outlining aims, endpoints, and cohorts.</li>
          <li>Provide IRB status (if applicable) and a short data‑security plan.</li>
          <li>Agree to data‑use terms and attribution language.</li>
        </ol>

        <div style="margin-top:12px; display:flex; gap:10px; flex-wrap:wrap;">
          contact.html#biobankStart a Request</a>
          privacy.html#data-useData Use & Privacy</a>
        </div>
      </div>

    </div>
  </section>


  <!-- FAQ -->
  <section class="section-tight">
    <h2>Frequently asked</h2>

    <div class="grid" style="grid-template-columns:repeat(auto-fit,minmax(260px,1fr));">

      <div class="card-mini">
        <h4>Do you share raw or processed data?</h4>
        <p class="small">
          Both may be supported depending on consent scope. Raw data for discovery; processed
          outputs for validation.
        </p>
      </div>

      <div class="card-mini">
        <h4>Turnaround time</h4>
        <p class="small">
          Timelines vary with study complexity. Validation‑focused work is generally faster than
          multi‑arm discovery projects.
        </p>
      </div>

    </div>
  </section>

</main>


<!-- ======================================
     FOOTER
======================================= -->
<footer>
  <div class="container footer-grid">

    <div>
      <strong>LiquidMammo™</strong><br />
      A test developed by MultiOmics Inc.
      <p class="footer-note">
        MultiOmics Inc. is headquartered in Washington, DC and operates out of
        LabCentral in Cambridge, MA.
      </p>
    </div>

    <div class="footer-logo" style="justify-content:flex-end; text-align:right;">
      assets/logos/multiomics-logo.png
      <div class="footer-note" style="line-height:1.2">
        Developed by<br />MultiOmics Inc.
      </div>
    </div>

  </div>

  <div class="container footer-note" style="margin-top:20px;">
    © <script>document.write(new Date().getFullYear())</script>
    MultiOmics Inc. •
    privacy.htmlPrivacy & Compliance</a> •
    contact.htmlContact</a>
  </div>
</footer>

</body>
</html>
